SomaGenics Inc.

Precision drug-delivery devices with the ability to provide precise doses of drugs to specific sites or tightly-controlled sustained release of a drug are poised to transform many sectors of medicine.

Start-ups aim to rejuvenate medical dermatology. A few private investors are betting that dermatology may be the new ophthalmology. Just a few years ago that sector was viewed as a pharmaceutical back

The Silence of the Genes Gene silencing—down-regulating the expression of a specific gene-product, or protein—is an invaluable tool used by researchers to validate drug targets. Of the many ways scien

A bevy of start-ups are betting that RNAi, a newly discovered mechanism of cellular defense, can be harnessed to create highly specific gene-inhibiting therapeutics. by Deborah Erickson When people ta